Lipidomic Signatures in Feline Disease: A PRISMA-Guided Systematic Review
Metabolites · 15.05.2026 · 16 (5) · 330
DOI: 10.3390/metabo16050330 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 15.05.2026. Verfasst von Ana Carolina Fontes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Sciences, School of Agricultural and Veterinary Sciences (ECAV), University of Trás-os-Montes and Alto Douro, 5000-801 Vila …. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Fundação para a Ciência e a Tecnologia, University of Aveiro.
Abstract (Originalsprache)
Background/Objectives: Lipidomics has become a key component of systems biology, enabling comprehensive characterisation of lipid species and their roles in health and disease. As regulators of membrane architecture, energy balance, inflammation, and cellular signalling, lipids offer a powerful framework for understanding metabolic dysfunction. In veterinary medicine, however, lipidomics remains comparatively underdeveloped. In cats, lipid metabolism is central to disorders such as hepatic lipidosis, cystitis, obesity, diabetes mellitus, and chronic inflammatory enteropathies, yet available data remain limited. This systematic review synthesised current evidence on lipidomics and lipid-focused profiling in feline disease and identified lipid alterations with potential clinical relevance.
Methods
Following PRISMA 2020 guidelines, PubMed, ScienceDirect, and Scopus were searched for original studies (1994–2026) evaluating lipidomics or lipid-focused profiling in cats. Eligible studies assessed lipid species, fatty acids, lipid mediators, or lipoproteins in disease or physiological states. Owing to methodological heterogeneity, findings were synthesised narratively.
Results
Seventeen studies met inclusion criteria, covering hepatic, urinary, gastrointestinal, renal, neurological, oncological, metabolic, and pharmacologically modulated conditions. Recurring alterations involved lipoproteins, triglycerides, phospholipids, sphingolipids, fatty acids, and oxylipins. More consistent patterns emerged in hepatic lipidosis, where lipoprotein disturbances may aid diagnosis; in lower urinary tract disease, where PUFA-derived oxylipins differentiated bacterial from idiopathic cystitis; and in obesity, where phospholipid and triglyceride shifts reflected metabolic risk. Fatty acid remodelling in chronic enteropathies aligned with mucosal inflammation, while sphingolipid changes in neurological disease correlated with severity. Heterogeneity in analytical platforms, dietary control, and study design limited comparability.
Conclusions
Feline lipidomics reveals biologically meaningful alterations with emerging diagnostic and prognostic value. Although still developing, lipid-focused approaches may enhance disease characterisation and support translational research. Larger, standardised studies and robust reference datasets are needed to validate lipid signatures for clinical implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterinary Sciences, School of Agricultural and Veterinary Sciences (ECAV), University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal.
- Animal and Veterinary Research Center (CECAV)-AL4AnimalS, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal.
- Chemistry Center of Vila Real, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal.
- RISE-Health-Health Research Network, Faculty of Medicine, University of Porto, 4099-002 Porto, Portugal.
- CESAM, Departament of Chemistry, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal.
- Mass Spectrometry Centre, LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.
ORCID-Profile: Carolina Santos Silva, Isabel Ribeiro Dias, Francisco Peixoto, Maria Manuel Oliveira, Maria Rosario Domingues, Carlos Antunes Viegas
Förderung
- Fundação para a Ciência e Tecnologia
- Fundação para a Ciência e a Tecnologia
- University of Aveiro
- Fundação para a Ciência e a Tecnologia, I. P.
- Ministério da Ciência e Tecnologia
- CESAM
- LAQV-REQUIMTE
- ERDF
Zitieren
APA
Fontes, A. C., Silva, C. S., Matos, A. C., Dias, I. R., Peixoto, F., Oliveira, M. M., Domingues, M. R., & Viegas, C. A. (2026). Lipidomic Signatures in Feline Disease: A PRISMA-Guided Systematic Review. Metabolites, 16(5), 330. https://doi.org/10.3390/metabo16050330
Vancouver
Fontes AC, Silva CS, Matos AC, Dias IR, Peixoto F, Oliveira MM, et al. Lipidomic Signatures in Feline Disease: A PRISMA-Guided Systematic Review. Metabolites. 2026;16(5):330. doi:10.3390/metabo16050330
BibTeX
@article{Fontes2026,
author = {Fontes, Ana Carolina and Silva, Carolina Santos and Matos, Ana Carolina and Dias, Isabel Ribeiro and Peixoto, Francisco and Oliveira, Maria Manuel and Domingues, Maria Rosario and Viegas, Carlos Antunes},
title = {Lipidomic Signatures in Feline Disease: A PRISMA-Guided Systematic Review},
journal = {Metabolites},
year = {2026},
volume = {16},
number = {5},
pages = {330},
doi = {10.3390/metabo16050330}
}
EUVIMED